Stock JFLLIFE JFL LIFE SCIENCES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials JFL Life Sciences Limited

Equities

JFLLIFE

INE0LA901015

Pharmaceuticals

Market Closed - NSE India S.E.
Other stock markets
 07:40:29 2024-07-05 am EDT 		5-day change 1st Jan Change
58.55 INR +19.98% Intraday chart for JFL Life Sciences Limited +45.65% +41.08%
2023 JFL Life Sciences Limited Reports Earnings Results for the Half Year Ended September 30, 2023 CI
2023 Certain Equity Shares of JFL Life Sciences Limited are subject to a Lock-Up Agreement Ending on 5-SEP-2023. CI

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022
Net sales 1 317.8 301.7 327.7 271.8
EBITDA 1 13.21 18.63 21.62 49.83
EBIT 1 11.67 16.26 18.86 45.78
Operating Margin 3.67% 5.39% 5.75% 16.84%
Earnings before Tax (EBT) 1 4.228 4.97 7.466 37.2
Net income 1 3.025 3.604 5.421 27.63
Net margin 0.95% 1.19% 1.65% 10.17%
EPS 2 0.5877 0.6555 0.8900 4.113
Free Cash Flow - 1.412 -77.46 -
FCF margin - 0.47% -23.63% -
FCF Conversion (EBITDA) - 7.58% - -
FCF Conversion (Net income) - 39.16% - -
Dividend per Share - - - -
Announcement Date 4/12/22 4/12/22 4/12/22 4/12/22
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022
Net Debt 1 83.8 90.2 168 157
Net Cash position 1 - - - -
Leverage (Debt/EBITDA) 6.341 x 4.844 x 7.759 x 3.143 x
Free Cash Flow - 1.41 -77.5 -
ROE (net income / shareholders' equity) - 6.94% 8.85% -
ROA (Net income/ Total Assets) - 5.02% 4.42% -
Assets 1 - 71.77 122.6 -
Book Value Per Share 2 9.740 9.780 11.30 13.70
Cash Flow per Share 2 0.0600 0.5400 0.0600 0.4200
Capex 1 6.11 27.8 17.2 10.5
Capex / Sales 1.92% 9.21% 5.26% 3.88%
Announcement Date 4/12/22 4/12/22 4/12/22 4/12/22
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
JFL LIFE SCIENCES LIMITED Stock JFL Life Sciences Limited
+41.08% 6.43M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+56.89% 809B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+39.52% 624B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.55% 351B
ABBVIE INC. Stock AbbVie Inc.
+7.92% 289B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.74% 240B
NOVARTIS AG Stock Novartis AG
+13.83% 220B
ROCHE HOLDING AG Stock Roche Holding AG
-0.49% 219B
AMGEN INC. Stock Amgen Inc.
+7.94% 166B
PFIZER, INC. Stock Pfizer, Inc.
-2.57% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. JFLLIFE Stock
  4. Financials JFL Life Sciences Limited